In addition, when the effects of TNF-α inhibitors on IL-17 in patients with RA were evaluated, it was found that the beneficial effects of anti-TNF-α therapy might involve a decrease in IL-17 in responders (35). The gene discussed is IL17A; the disease is rheumatoid arthritis.